UofT Libraries is getting a new library services platform in January 2021.
Learn more about the change.

Search Articles

X
Search Filters
Format Format
Subjects Subjects
Subjects Subjects
X
Sort by Item Count (A-Z)
Filter by Count
humans (1049) 1049
science & technology (879) 879
life sciences & biomedicine (814) 814
female (737) 737
bridged-ring compounds - therapeutic use (644) 644
middle aged (483) 483
oncology (472) 472
adult (407) 407
aged (404) 404
male (388) 388
antineoplastic combined chemotherapy protocols - therapeutic use (380) 380
animals (378) 378
bridged-ring compounds - administration & dosage (371) 371
breast neoplasms - drug therapy (339) 339
taxoids - therapeutic use (324) 324
chemotherapy (287) 287
bridged-ring compounds - pharmacology (286) 286
taxoids - administration & dosage (283) 283
biological and medical sciences (276) 276
medical sciences (261) 261
antineoplastic agents - therapeutic use (240) 240
treatment outcome (238) 238
cancer (237) 237
breast cancer (224) 224
breast neoplasms - pathology (202) 202
pharmacology & pharmacy (190) 190
mice (176) 176
pharmacology. drug treatments (161) 161
tumors (159) 159
taxoids (139) 139
retrospective studies (134) 134
rats (128) 128
disease-free survival (125) 125
neoplasm staging (125) 125
prognosis (123) 123
aged, 80 and over (121) 121
bridged-ring compounds - adverse effects (120) 120
antineoplastic agents (119) 119
bridged-ring compounds - chemistry (118) 118
care and treatment (114) 114
chemotherapy, adjuvant (109) 109
drug resistance, neoplasm (109) 109
analysis (108) 108
research (107) 107
anthracyclines - therapeutic use (103) 103
bridged bicyclo compounds - therapeutic use (101) 101
taxane (101) 101
medicine & public health (98) 98
deoxycytidine - analogs & derivatives (96) 96
ovarian neoplasms - drug therapy (93) 93
taxoids - adverse effects (93) 93
anthracyclines - administration & dosage (92) 92
neoadjuvant therapy (92) 92
dose-response relationship, drug (91) 91
antineoplastic combined chemotherapy protocols - adverse effects (90) 90
survival rate (88) 88
clinical trials as topic (87) 87
gynecology. andrology. obstetrics (84) 84
neoplasm metastasis (84) 84
taxoids - pharmacology (79) 79
cell line, tumor (78) 78
hematology, oncology and palliative medicine (77) 77
survival analysis (77) 77
monoterpenes (75) 75
abridged index medicus (74) 74
metastasis (74) 74
time factors (74) 74
drug administration schedule (73) 73
antineoplastic agents - pharmacology (69) 69
paclitaxel (69) 69
breast neoplasms - mortality (68) 68
deoxycytidine - administration & dosage (68) 68
health aspects (68) 68
lung neoplasms - drug therapy (68) 68
antineoplastic agents - adverse effects (67) 67
follow-up studies (65) 65
ovarian cancer (65) 65
breast neoplasms - metabolism (64) 64
chemistry (64) 64
fluorouracil - administration & dosage (63) 63
anthracyclines (62) 62
cisplatin - administration & dosage (62) 62
survival (61) 61
trastuzumab (61) 61
receptor, erbb-2 - metabolism (60) 60
taxanes (60) 60
mammary gland diseases (59) 59
cancer therapies (58) 58
drug therapy (57) 57
obstetrics & gynecology (57) 57
biochemistry & molecular biology (56) 56
carcinoma, non-small-cell lung - drug therapy (55) 55
chemistry, medicinal (55) 55
ramipril (55) 55
docetaxel (54) 54
antineoplastic agents - administration & dosage (53) 53
physical sciences (52) 52
disease models, animal (51) 51
bridged-ring compounds - chemical synthesis (50) 50
young adult (50) 50
more...
Language Language
Language Language
X
Sort by Item Count (A-Z)
Filter by Count
English (1241) 1241
Japanese (48) 48
Russian (26) 26
Chinese (23) 23
German (17) 17
Italian (14) 14
French (12) 12
Spanish (3) 3
Bulgarian (1) 1
Finnish (1) 1
more...
Publication Date Publication Date
Click on a bar to filter by decade
Slide to change publication date range


Annals of oncology, ISSN 0923-7534, 12/2018, Volume 29, Issue 12, pp. 2341 - 2347
Journal Article
Oncogene, ISSN 0950-9232, 10/2020, Volume 39, Issue 42, pp. 6589 - 6605
Biochemistry & Molecular Biology | Oncology | Genetics & Heredity | Life Sciences & Biomedicine | Science & Technology | Cell Biology | Anilides - therapeutic use | Pyrazoles - therapeutic use | Alternative Splicing | Zinc Finger Protein GLI1 - metabolism | Neoplastic Stem Cells - drug effects | Humans | Receptor, ErbB-2 - metabolism | Drug Resistance, Neoplasm | Smoothened Receptor - metabolism | Triple Negative Breast Neoplasms - drug therapy | Biphenyl Compounds - therapeutic use | Antineoplastic Combined Chemotherapy Protocols - pharmacology | Biphenyl Compounds - pharmacology | Neoplasm Metastasis - drug therapy | Janus Kinase 2 - metabolism | Bridged-Ring Compounds - pharmacology | Triple Negative Breast Neoplasms - pathology | Neoplastic Stem Cells - pathology | Female | Trastuzumab - pharmacology | Smoothened Receptor - antagonists & inhibitors | Janus Kinase 2 - antagonists & inhibitors | STAT3 Transcription Factor - metabolism | Pyrazoles - pharmacology | Pyridines - therapeutic use | Bridged-Ring Compounds - therapeutic use | Trastuzumab - therapeutic use | Zinc Finger Protein GLI1 - genetics | Pyrimidines - pharmacology | Drug Synergism | Xenograft Model Antitumor Assays | Animals | Signal Transduction - drug effects | Antineoplastic Combined Chemotherapy Protocols - therapeutic use | Neoplasm Metastasis - pathology | Protein Kinase Inhibitors - therapeutic use | Pyrimidines - therapeutic use | Anilides - pharmacology | Cell Line, Tumor | Mice | Protein Kinase Inhibitors - pharmacology | Pyridines - pharmacology | Antimitotic agents | Prognosis | Growth | Stem cells | Breast cancer | Metastasis | Antineoplastic agents | Vascular endothelial growth factor | Toxicity | Lung cancer | Stat3 protein | Stem cell transplantation | Cancer therapies | ErbB-2 protein | Metastases | Medical prognosis | Janus kinase 2 | Xenografts | Trastuzumab | Tumors | Index Medicus
Journal Article
The lancet oncology, ISSN 1470-2045, 2017, Volume 18, Issue 5, pp. 640 - 653
Journal Article
Journal Article
Biochemical pharmacology, ISSN 0006-2952, 09/2012, Volume 84, Issue 6, pp. 830 - 837
Journal Article